Xilio Development Inc
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which compr… Read more
Xilio Development Inc (XLO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 2.161x
Based on the latest financial reports, Xilio Development Inc (XLO) has a cash flow conversion efficiency ratio of 2.161x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.50 Million) by net assets ($-8.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Xilio Development Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Xilio Development Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Xilio Development Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xilio Development Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jantsa Jant Sanayi ve Ticaret AS
IS:JANTS
|
0.132x |
|
James Bay Minerals Ltd
AU:JBY
|
N/A |
|
Sanghi Industries Limited
NSE:SANGHIIND
|
0.275x |
|
Samart Aviation Solutions Public Company Limited
BK:SAV
|
0.142x |
|
Hanjin Heavy Ind & Const Holdings Co Ltd
KO:003480
|
0.039x |
|
Alarko Carrier Sanayi ve Ticaret AS
IS:ALCAR
|
-0.001x |
|
EMBARK EDUCATION LTD.
F:9EV
|
N/A |
|
INSTAL KRAKÓW SA
WAR:INK
|
0.049x |
Annual Cash Flow Conversion Efficiency for Xilio Development Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Xilio Development Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $17.60 Million | $-18.38 Million | -1.044x | +43.95% |
| 2023-12-31 | $36.83 Million | $-68.62 Million | -1.863x | -159.96% |
| 2022-12-31 | $105.65 Million | $-75.72 Million | -0.717x | -64.59% |
| 2021-12-31 | $185.43 Million | $-80.75 Million | -0.435x | -106.38% |
| 2020-12-31 | $-5.29 Million | $-36.09 Million | 6.829x | +1573.87% |
| 2019-12-31 | $38.51 Million | $-17.84 Million | -0.463x | -- |